Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2025
DOI: 10.1002/phar.70031 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2025. Verfasst von Brian W Gilbert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wesley Medical Center, Wichita, Kansas, USA. Hauptthemen laut MEDLINE: Rivastigmine, Diphenhydramine, Cholinesterase Inhibitors, Cholinergic Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Diphenhydramine overdose is a common toxicological emergency characterized by anticholinergic symptoms such as delirium, hallucinations, and cardiovascular instability. Physostigmine, a centrally acting acetylcholinesterase inhibitor, is the standard antidote but is currently unavailable within the United States due to supply limitations. We present the case of a 21‐year‐old female with confirmed diphenhydramine overdose (3600 mg) who demonstrated rapid clinical improvement after administration of a 9.5 mg/24‐h rivastigmine transdermal patch. This case supports growing evidence suggesting that rivastigmine may serve as a safe and effective alternative when physostigmine is not accessible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wesley Medical Center, Wichita, Kansas, USA.
- Jackson Memorial Hospital, Miami, Florida, USA.
ORCID-Profile: Brian W Gilbert
Zitieren
APA
Gilbert, B. W., Santiago, R. D., Huffman, J. B., Yoder, N. M., & Hunninghake, J. C. (2025). Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70031
Vancouver
Gilbert BW, Santiago RD, Huffman JB, Yoder NM, Hunninghake JC. Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2025. doi:10.1002/phar.70031
BibTeX
@article{Gilbert2025,
author = {Gilbert, Brian W and Santiago, Ruben D and Huffman, Joel B and Yoder, Nathaniel M and Hunninghake, John C},
title = {Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2025},
doi = {10.1002/phar.70031}
}
EUVIMED